Operational research to develop an M&E strategy to guide triple drug stopping decisions for lymphatic filariasis in Egypt

What is the indicator(s) and accompanying monitoring and evaluation (M&E) strategy that enables country programs to determine when the risk of ongoing transmission of LF has been reduced so that IDA can be stopped with little risk of resurgence of transmission?


Sample size: 2 000
Implementation partner(s): Ministry of Health and Population - Egypt
WHO Region: EMRO


Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt

Reda M.R.Ramzy, Hussein A.Kamal, Mohamed A.Hassan, Ayat A.Haggagb
2019, Issue no. 199, pages 105121


Principal Investigator is independent consultant Dr. Reda Ramzy, with funding administered through The Eastern Mediterranean Public Health Network (EMPHNET).

Email primary contact

Please log in or register